DUBLIN--(BUSINESS WIRE)--The "Lung Cancer Therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global lung cancer therapeutics market to grow with a CAGR of 12.5% over the forecast period of 2018-2024. The study on lung cancer therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
The report on lung cancer therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global lung cancer therapeutics market over the period of 2016 to 2024.
Key Topics Covered
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Lung Cancer Therapeutics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.5. Competitive Landscape in the Global Lung Cancer Therapeutics Market
4. Global Lung Cancer Therapeutics Market by Type of Molecule
4.1. Small Molecules
4.2. Biologics
5. Global Lung Cancer Therapeutics Market by Disease Type
5.1. NSCLC
5.2. SCLC
6. Global Lung Cancer Therapeutics Market by Region 2018-2024
6.1. North America
6.2. Europe
6.3. Asia-Pacific
6.4. RoW
7. Company Covered
7.1. Astellas Pharma
7.2. Pfizer
7.3. Amgen
7.4. Celgene
7.5. Astrazeneca
7.6. F. Hofmann-la Roche
7.7. Glaxosmithkline
7.8. Aetna, Agennix
7.9. Eli Lilly
7.10. Boston Biomedical
For more information about this report visit https://www.researchandmarkets.com/research/skn5nd/lung_cancer?w=4
